Evidence map›Paper›PMID 27348307›Full record

ArticlePloS one2016

P2A-Fluorophore Tagging of BRAF Tightly Links Expression to Fluorescence In Vivo.

J Edward van Veen, Daphne R Pringle, Martin McMahon

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

J Edward van VeenHelen Diller Family Comprehensive Cancer, University of California San Francisco, San Francisco, CA, United States of America.ORCID http://orcid.org/0000-0003-1798-3210
Daphne R PringleHelen Diller Family Comprehensive Cancer, University of California San Francisco, San Francisco, CA, United States of America.
Martin McMahonHelen Diller Family Comprehensive Cancer, University of California San Francisco, San Francisco, CA, United States of America.

Funding

Molecular and Cellular Mechanisms in CancerT32CA108462 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI · 2004 to 2024
$10.4M
Studying the initiation, progression and therapy of lung cancer in mouse modelsR01CA131261 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MARTIN MCMAHON · 2009 to 2026
$5.3M
Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma TherapyR01CA176839 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MARTIN MCMAHON · 2013 to 2026
$2.9M
Defining the contributions by macrophages in BRAFV600E induced lung tumorigenesisF32CA196000 · NCI · UNIVERSITY OF UTAH · PI PRINGLE, DAPHNE R · 2015 to 2017
$159k
NCI NIH HHS F32 CA196000NCI NIH HHS R01 CA131261NCI NIH HHS R01 CA176839NCI NIH HHS T32 CA108462
6 · The paper itself

Abstract

The Braf proto-oncogene is a key component of the mitogen-activated protein kinase signaling cascade and is a critical regulator of both normal development and tumorigenesis in a variety of tissues. In order to elucidate BRAF's differing roles in varying cell types, it is important to understand both the pattern and timing of BRAF expression. Here we report the production of a mouse model that links the expression of Braf with the bright red fluorescent protein, tdTomato. We have utilized a P2A knock-in strategy, ensuring that BRAF and the fluorophore are expressed from the same endogenous promoter and from the same bicistronic mRNA transcript. This mouse model (BrafTOM) shows bright red fluorescence in organs and cell types known to be sensitive to BRAF perturbation. We further show that on a cell-by-cell basis, fluorescence correlates with BRAF protein levels. Finally, we extend the utility of this mouse by demonstrating that the remnant P2A fragment attached to BRAF acts as a suitable epitope for immunoprecipitation and biochemical characterization of BRAF in vivo.

Indexed as

AnimalsFlow CytometryLuminescent ProteinsMiceMicroscopy, FluorescenceOptical ImagingProtein DomainsProto-Oncogene Proteins B-rafRecombinant ProteinsRed Fluorescent ProteinBraf protein, mouseLuminescent ProteinsProto-Oncogene Proteins B-rafRecombinant ProteinsRed Fluorescent Protein

Identifiers

PMID27348307
PMCPMC4922626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.